A whole-genome analysis of allelic changes in renal cell carcinoma by in-gel competitive reassociation

Molecular Carcinogenesis

Volumn 22, Issue 3, 1998, Pages 158-166

  Ohki, Rieko ^a   Oishi, Michio ^b,c   Kiyama, Ryoiti ^a,b,d  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATL INST BIOSCI HUM TECHNOL   (Japan)

^c KAZUSA DNA RESEARCH INSTITUTE   (Japan)

^d Ministry of International Trade and Industry   (Japan)

Author keywords

DNA subtraction; Loss of heterozygosity; Renal cell carcinoma

Indexed keywords

ARTICLE; CHROMOSOME 8; CHROMOSOME 9; CONTROLLED STUDY; GENE MAPPING; GENETIC ANALYSIS; GENOME; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MOLECULAR CLONING; PRIORITY JOURNAL;

ALLELES; ANIMALS; BASE SEQUENCE; BLOTTING, SOUTHERN; CARCINOMA, RENAL CELL; CLONING, MOLECULAR; DNA PRIMERS; DNA, SATELLITE; GENETIC TECHNIQUES; GENOME; HUMANS; KIDNEY NEOPLASMS; MICE;

EID: 0031855372     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199807)22:3<158::AID-MC3>3.0.CO;2-H     Document Type: Article

References (42)

1. Morita R, Ishikawa J, Tsutsumi M, et al. Allelotype of renal cell carcinoma. Cancer Res 51:820-823, 1991.
2. Ogawa O, Kakehi Y, Ogawa K, Koshiba M, Sugiyama T, Yoshiba O. Allelic loss of chromosome 3p characterizes clear cell phenotype of renal cell carcinoma. Cancer Res 51:949-953, 1991.
3. Presti JJC, Reuter VE, Cordon-Cardo C, Mazumdar M, Fair WR, Jhanwar SC. Allelic deletions in renal tumors: Histopathological correlations. Cancer Res 53:5780-5783, 1993.
4. Cairns P, Tokino K, Eby Y, Sidransky D. Localization of tumor suppressor loci on chromosome 9 in primary human renal cell carcinomas. Cancer Res 55:224-227, 1995.
5. Druck T, Kastury K, Hadaczek P, et al. Loss of heterozygosity at the familial RCC t(3;8) locus in most clear cell renal carcinomas. Cancer Res 55:5348-5353, 1995.
6. Wilhelm M, Bugert P, Kenck C, Staehler G, Kovacs G. Terminal deletion of chromosome 3p sequences in nonpapillary renal cell carcinomas: A breakpoint cluster between loci D3S1285 and D3S1603. Cancer Res 55:5383-5385, 1995.
7. Schwerdtle RF, Storkel S, Neuhaus C, et al. Allelic losses at chromosomes 1p, 2p, 6p, 10p, 13q, 17p, and 21q significantly correlate with the chromophobe subtype of renal cell carcinoma. Cancer Res 56:2927-2930, 1996.
8. Latif F, Tory K, Gnarra JR, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260:1317-1320, 1993.
9. Gnarra JR, Tory K, Weng Y, et al. Mutations of the VHL tumor suppressor gene in renal carcinoma. Nat Genet 7:85-90, 1994.
10. Shuin T, Kondo K, Torigoe S, et al. Frequent somatic mutations and loss of heterozygosity of the von Nippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res 54:2852-2855, 1994.
11. Speicher MR, Schoell B, du Manoir S, et al. Specific loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization. Am J Pathol 145:356-364, 1994.
12. Lisitsyn NA, Lisitsina NM, Dalbagni G, et al. Comparative genomic analysis of tumors: Detection of DNA losses and amplification. Proc Natl Acad Sci USA 92:151-155, 1995.
13. Moch H, Presti JJC, Sauter G, et al. Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma. Cancer Res 56:27-30, 1996.
14. Foster K, Crossey PA, Cairns P, et al. Molecular genetic investigation of sporadic renal cell carcinoma: Analysis of allele loss on chromosomes 3p, 5q, 11p, 17 and 22. Br J Cancer 69:230-234, 1994.
15. Thrash-Bingham CA, Greenberg RE, Howard S, et al. Comprehensive allelotyping of human renal cell carcinomas using microsatellite DNA probes. Proc Natl Acad Sci USA 92:2854-2858, 1995.
16. Thrash-Bingham CA, Salazar H, Freed JJ, Greenberg RE, Tartof. KD. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology. Cancer Res 55:6189-6195, 1995.
17. Yokota H, Oishi M. Differential cloning of genomic DNA: Cloning of DNA with an altered primary structure by in-gel competitive reassociation. Proc Natl Acad Sci USA 87:6398-6402, 1990.
18. Yokota H, Iwasaki T, Takahashi M, Oishi M. Tissue-specific-change in repetitive DNA in rats. Proc Natl Acad Sci USA 86:9223-9237, 1989.
19. Kiyama R, Inoue S, Ohki R, Kikuya E, Yokota H, Oishi M. A differential cloning procedure for rearranged or altered genomic DNA based on in-gel competitive reassociation. Adv Biophys 31:151-161, 1995.
20. Iwasaki T, Ohki R, Kiyama R, Oishi M. Analysis of recombination junctions in extrachromosomal circular DNA obtained by in-gel competitive reassociation. FEBS Lett 363:239-245, 1995.
21. Inoue S, Kiyama R, Oishi M. Construction of highly extensive polymorphic DNA libraries by in-gel competitive reassociation procedure. Genomics 31:271-276, 1996.
22. Mizuguchi R, Inoue S, Kiyama R, Oishi M. Construction of libraries for methylation sites by in-gel competitive reassociation (IGCR). DNA Res 2:219-223, 1995.
23. Sasaki H, Nomura S, Akiyama N, et al. Highly efficient method for obtaining a subtracted genomic DNA library by the modified in-gel competitive reassociation method. Cancer Res 54:5821-5823, 1994.
24. Yokota H, Amano S, Yamane T, Ataka K, Kikuya E, Oishi M. A differential cloning procedure of complex genomic DNA fragments. Anal Biochem 219:131-138, 1994.
25. Gazin C, Dupont S, de Dinechin D, et al. Nucleotide sequence of the human c-myc locus: Provocative open reading frame within the first exon. EMBO J 3:383-387, 1984.
26. Greenwald BD, Harpaz N, Yin J, et al. Loss of heterozygosity affecting the p53, Rb, and mcc/apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis. Cancer Res 52:741-745, 1992.
27. Gyapay G, Morissette J, Vignal A, et al. The 1993-94 Genethon human genetic linkage map. Nat Genet 7:246-339, 1994.
28. Zielenski J, Markiewicz D, Rininsland F, Rommens J, Tsui LC. A cluster of highly polymorphic dinucleotide repeats in intron 17b of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Arn J Hum Genet 49:1256-1262, 1991.
29. Deng G, Chen L-C, Schott DR, et al. Loss of heterozygosity and p53 gene mutations in breast cancer. Cancer Res 54:499-505, 1994.
30. 2+-dependent triplex affinity capture. J Biol Chem 270:9258-9264, 1995.
31. Frommer M, Prosser J, Vincent PC. Human satellite I sequences include a male specific 2.47 kb tandemly repeated unit containing one Alu family member per repeat. Nucleic Acids Res 12:2887-2900, 1984.
32. Mor O, Messinger Y, Rotman G, et al. Novel DNA sequences at chromosome 10q26 are amplified in human gastric carcinoma cell lines: Molecular cloning by competitive DNA reassociation. Nucleic Acids Res 19:117-123, 1991.
33. Nakatani H, Sakamoto H, Yoshida T, et al. Isolation of an amplified DNA sequence in stomach cancer. Jpn J Cancer Res 81:707-710, 1990.
34. Heerdt BG, Chen J, Stewart LR, Augenlicht LH. Polymorphisms, but lack of mutations or instability, in the promoter region of the mitochondrial genome in human colonic tumors. Cancer Res 54:3912-3915, 1994.
35. Kovacs A, Storkel S, Thoenes W, Kovacs G. Mitochondrial and chromosomal DNA alterations in human chromophobe renal cell carcinomas. J Pathol 167:273-277, 1992.
36. Bianchi MS, Bianchi NO, Bailliet G. Mitochondrial DNA mutations in normal and tumor tissues from breast cancer patients. Cytogenet Cell Genet 71:99-103, 1995.
37. Tallini G, Ladanyi M, Rosai J, Jhanwar SC. Analysis of nuclear and mitochondrial DNA alterations in thyroid and renal oncocytic tumors. Cytogenet Cell Genet 66:253-259, 1994.
38. van Slegtenhorst M, de Hoogt R, Hermans C, et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277:805-808, 1997.
39. Sampson JR, Patel A, Mee AD. Multifocal renal cell carcinoma in sibs from a chromosome 9 linked (TSC1) tuberous sclerosis family. J Med Genet 32:848-850, 1995.
40. Simoneau AR, Spruck CH 3rd, Gonzalez-Zulueta M, et al. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations. Cancer Res 56:5039-5043, 1996.
41. Oda H, Nakatsuru Y, Ishikawa T. Mutations of the p53 gene and p53 protein overexpression are associated with sarcomatoid transformation in renal cell carcinomas. Cancer Res 55:658-662, 1995.
42. Xu Y-H, Ishii S, Clark AJL, et al. Human epidermal growth factor receptor cDNA is homologous to a variety of RNAs overproduced in A431 carcinoma cells. Nature 309:806-810, 1984.